The thyroid hormone activating enzyme, DIO2, is a potential pan-cancer biomarker and immunotherapy target. Nappi A, Miro C, Cicatiello AG, Sagliocchi S, et al. J Endocrinol Invest 2025 Jan 17. doi: 10.1007/s40618-024-02526.

Read + Share

Amedeo Smart

Independent Medical Education

Nappi A, Miro C, Cicatiello AG, Sagliocchi S, et al. The thyroid hormone activating enzyme, DIO2, is a potential pan-cancer biomarker and immunotherapy target. J Endocrinol Invest 2025 Jan 17. doi: 10.1007/s40618-024-02526.
PMID: 39821172